Andrew Oskoui, CFA, is the portfolio manager and principal of Blue Tower Asset Management. Andrew previously worked in investment research for YCG and managed an equity strategy for Allometric Research & Management. Andrew has a Bachelor of Science in Biomedical Engineering from Washington University in St. Louis, and a Master's Degree in Chemistry from the University of Wisconsin-Madison. Andrew passed all three levels of the CFA exam on his first attempt. Prior to beginning his career in finance, Andrew led a materials science research group for Halcyon Molecular (a Founder's Fund portfolio company) and researched nanoparticle drug delivery for cancer therapies as an engineer for Covidien.